4.21 USD
↗ 0.11 (2.68%)PRE MARKET (AS OF 07:51 AM EDT)
Protara Therapeutics, Inc. Common Stock
TARANASDAQ • USD
Market: OPEN
Protara Therapeutics, Inc. Common Stock (TARA) is currently trading at $4.21. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 6, 2026.
Open?$4.10
High?$4.21
Low?$4.10
Prev. Close?$4.10
Volume?77
Avg. Volume?608.1K
VWAP?$4.18
Rel. Volume?0.00x
Bid / Ask
Bid?$4.08 × 100
Ask?$4.84 × 100
Spread?$0.76
Midpoint?$4.46
Valuation & Ratios
Market Cap?230.4M
Shares Out?56.2M
Float?48.8M
Float %?86.9%
P/E Ratio?N/A
P/B Ratio?1.27
EPS?-$1.13
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Themes
Employees
51
Market Cap
224.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-01-10
Address
345 PARK AVENUE SOUTH
NEW YORK, NY 10010
Phone: 646-844-0337
NEW YORK, NY 10010
Phone: 646-844-0337
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?10.18Safe
Confidence?40%Low
Short InterestHigh
Short % of Float?9.30%Elevated
Short Interest?4.5M
Days to Cover?6.7
Free Float48.8M
Avg Daily Volume676.3K
Settlement Date2026-07-15
Financial Health
Current Ratio?15.69Strong
Quick Ratio?15.69Strong
Cash Ratio?1.65Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.27CHEAP▾
Peers100
S&P92
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-34.9%WEAK▾
S&P5
ROA?-33.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-63045000
Enterprise Value?$215.7M
Fundamentals ratios updated end of day